← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2020Last known activity
Jun 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (15 distinct, 6 trials)
Phase 2 (13 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06417086CollaboratorN/AJun 1, 2024
- NCT05352165OfficialN/AJan 1, 2023
- NCT05352165Lead sponsorN/AJan 1, 2023
- NCT05352165Overall official - principal investigatorN/AJan 1, 2023
- NCT05111860Lead sponsorPhase 1/Phase 2Nov 1, 2022
- NCT06036745Lead sponsorPhase 2Jul 1, 2022
- NCT05101616Lead sponsorPhase 1/Phase 2Jan 1, 2022
- NCT04620473Reponsible party - principal investigatorPhase 2Nov 1, 2020
- NCT04620473Lead sponsorPhase 2Nov 1, 2020
Details
- Last known activity
- Jun 1, 2024